MedPath

青岛科苑慧谷生物制药有限公司

Ownership
-
Established
1992-12-05
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:25

Drug Approvals

Busulfan Injection

Product Name
白消安注射液
Approval Number
国药准字H20153304
Approval Date
Feb 3, 2021
NMPA

Mannan Ester Tablets

Product Name
甘糖酯片
Approval Number
国药准字H37022968
Approval Date
Dec 23, 2020
NMPA

Alginic Sodium Diester Tablets

Product Name
藻酸双酯钠片
Approval Number
国药准字H37022262
Approval Date
Dec 23, 2020
NMPA

海麒舒肝胶囊

Approval Number
国药准字B20020216
Approval Date
Apr 10, 2015
NMPA

Mannan Ester

Product Name
甘糖酯
Approval Number
国药准字H37022967
Approval Date
Apr 10, 2015
NMPA

Glycyrrhetinic Acid

Product Name
甘草次酸
Approval Number
国药准字H15021234
Approval Date
Apr 10, 2015
NMPA

健脾消渴散

Approval Number
国药准字B20020359
Approval Date
Apr 10, 2015
NMPA

Alginic Sodium Diester

Product Name
藻酸双酯钠
Approval Number
国药准字H37022165
Approval Date
Apr 10, 2015
NMPA

Monoammonium Glycyrrhizinate A

Product Name
甘草酸单铵盐 a
Approval Number
国药准字H15021439
Approval Date
Apr 10, 2015
NMPA

Licorzine

Product Name
甘草锌
Approval Number
国药准字H15021235
Approval Date
Apr 10, 2015
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.